Cynthia Wibowo's Colleagues at Medistra Hospital
Cynthia Wibowo's Contact Details
["021-5210201","(618) 465-2020","021-5210 200","(021) 5210200","+62 21 5210184","021-5210200","021 5210200 ","021 5210201 ","021 5210184","021 5210201","+62 21 5210200","+62 21 5210201 ","+62-21-7505-980 (24","+62 21 5210200 ","(+62 21) 5210184","0800 1234 000"]
Indonesia
Medistra Hospital
Cynthia Wibowo's Company Details
MEDISTRA HOSPITAL is a private hospital that commenced its operation on November 28, 1991 and located in the heart of Jakarta. Medistra has been equipped with advanced medical technologies that deliver excellent facilities and services by highly regarded specialist. In line with rapid development of health technology, Medistra keeps upgrading its facilities and increasing the quality of services. Medistra has 40 outpatient clinics with the average of Specialist Outpatients Clinic attendances about 90.000 patient per year. The total beds capacity is 191 beds with the average of patient admission 8.500 patients per year.Medistra has its strength consists of Cardiovascular, Digestive Disease & GI Oncology, Orthopedic and Neuroscience, etc. As the center of integrated health services in heart and blood vessel, there are numbers of services at Medistra cardiovascular center. Among the services are out patient clinic, medical check up, angiography, open heart surgery, rehabilitation services, etc. In addition, Medistra Cardiovascular Center provides medical supporting diagnostic such as Echocardiography, MSCT 256 Slices, MRI 1.5 Tesla, Catheterization laboratory and etc. The performance of Angiography is about 1.500 patients per year. This center is supported by well known specialists, such as Prof. Dr. T. Santoso S., Prof. Dr. Hanafi B. Trisnohadi, Sp.JP, KKV, Dr. Tamizi Hakim, Sp.BT, Dr. Dono Antono, Sp.Jp and many more.In line with the commitment of developing medical technology, Medistra has been developing the Stem Cell program which was first conceptualized early in 2006 as a formal and ongoing conduit for collaboration with The Faculty of Medicine of University of Indonesia. This program is designed to address the increasing importance, in both the conduct of research and the development of clinical applications, of interactions between the fields of stem cell science, ethics, and public policy.